Olle Lindvall

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.

Journal: Nature medicine
Published: February 16, 2026

STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease.

STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease.

Journal: BMJ open
Published: December 30, 2025

Human cortical neurons rapidly generated by embryonic stem cell programming integrate into the stroke-injured rat cortex.

Human cortical neurons rapidly generated by embryonic stem cell programming integrate into the stroke-injured rat cortex.

Journal: Stem cells (Dayton, Ohio)
Published: December 09, 2024

History of cellular grafting for central nervous system repair-A clinical perspective.

History of cellular grafting for central nervous system repair-A clinical perspective.

Journal: Handbook of clinical neurology
Published: September 28, 2024

The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.

The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.

Journal: Nature biotechnology
Published: August 10, 2023

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.

Journal: Cell stem cell
Published: March 17, 2023

Oligodendrocytes in human induced pluripotent stem cell-derived cortical grafts remyelinate adult rat and human cortical neurons.

Oligodendrocytes in human induced pluripotent stem cell-derived cortical grafts remyelinate adult rat and human cortical neurons.

Journal: Stem cell reports
Published: December 25, 2022

Long term outcome of children diagnosed with resignation syndrome in the Stockholm Region 2005-2012

Long term outcome of children diagnosed with resignation syndrome in the Stockholm Region 2005-2012

Journal: Lakartidningen
Published: June 22, 2022

The need for a standard for informed consent for collection of human fetal material.

The need for a standard for informed consent for collection of human fetal material.

Journal: Stem cell reports
Published: April 21, 2022

Balancing Expectations for Success in Stem Cell-Based Clinical Trials for Parkinson's Disease.

Balancing Expectations for Success in Stem Cell-Based Clinical Trials for Parkinson's Disease.

Journal: Cell stem cell
Published: October 02, 2020

Poly(ester amide) microspheres are efficient vehicles for long-term intracerebral growth factor delivery and improve functional recovery after stroke.

Poly(ester amide) microspheres are efficient vehicles for long-term intracerebral growth factor delivery and improve functional recovery after stroke.

Journal: Biomedical materials (Bristol, England)
Published: July 11, 2020

Blocking Notch-Signaling Increases Neurogenesis in the Striatum after Stroke.

Blocking Notch-Signaling Increases Neurogenesis in the Striatum after Stroke.

Journal: Cells
Published: June 13, 2020
Showing 1-12 of 66

Last Updated: 09/26/2026